JP2023538522A5 - - Google Patents
Info
- Publication number
- JP2023538522A5 JP2023538522A5 JP2023507911A JP2023507911A JP2023538522A5 JP 2023538522 A5 JP2023538522 A5 JP 2023538522A5 JP 2023507911 A JP2023507911 A JP 2023507911A JP 2023507911 A JP2023507911 A JP 2023507911A JP 2023538522 A5 JP2023538522 A5 JP 2023538522A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- approximately
- drug according
- statin
- combination drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063062990P | 2020-08-07 | 2020-08-07 | |
| US63/062,990 | 2020-08-07 | ||
| US202163135946P | 2021-01-11 | 2021-01-11 | |
| US63/135,946 | 2021-01-11 | ||
| PCT/US2021/045008 WO2022032137A1 (en) | 2020-08-07 | 2021-08-06 | Methods for treating refractory hypercholesterolemia involving an angptl3 inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538522A JP2023538522A (ja) | 2023-09-08 |
| JP2023538522A5 true JP2023538522A5 (enExample) | 2024-08-09 |
Family
ID=77543654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507911A Abandoned JP2023538522A (ja) | 2020-08-07 | 2021-08-06 | Ａｎｇｐｔｌ３阻害剤を伴う難治性高コレステロール血症を処置するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220072127A1 (enExample) |
| EP (1) | EP4192446A1 (enExample) |
| JP (1) | JP2023538522A (enExample) |
| KR (1) | KR20230050379A (enExample) |
| CN (1) | CN116096365A (enExample) |
| AU (1) | AU2021320417A1 (enExample) |
| BR (1) | BR112023002085A2 (enExample) |
| CA (1) | CA3188213A1 (enExample) |
| IL (1) | IL300429A (enExample) |
| MX (1) | MX2023001481A (enExample) |
| WO (1) | WO2022032137A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA43734A (fr) | 2016-03-03 | 2018-11-28 | Regeneron Pharma | Procédés de traitement de patients atteints d'hyperlipidémie par administration d'un inhibiteur de pcsk9 en combinaison avec un inhibiteur d'angptl3 |
| US12559551B2 (en) | 2019-05-24 | 2026-02-24 | Regeneron Pharmaceuticals, Inc. | Stabilized formulations containing anti-ANGPTL3 antibodies |
| WO2023196820A2 (en) * | 2022-04-04 | 2023-10-12 | Inozyme Pharma, Inc. | Treatment of enpp1 deficiency and abcc6 deficiency |
| WO2025185644A1 (zh) * | 2024-03-05 | 2025-09-12 | 江苏恒瑞医药股份有限公司 | 抗angptl3抗体治疗高血脂症的用途及方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| WO2012168491A1 (en) | 2011-06-10 | 2012-12-13 | Novartis Ag | Pharmaceutical formulations of pcsk9 antagonists |
| AR087305A1 (es) | 2011-07-28 | 2014-03-12 | Regeneron Pharma | Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit |
| EA039663B1 (ru) | 2012-05-03 | 2022-02-24 | Амген Инк. | Применение антитела против pcsk9 для снижения сывороточного холестерина лпнп и лечения связанных с холестерином расстройств |
| CA2955304C (en) * | 2014-07-16 | 2023-12-12 | Sanofi Biotechnology | Methods for treating high cardiovascular risk patients with hypercholesterolemia |
| KR20230074283A (ko) * | 2014-07-16 | 2023-05-26 | 사노피 바이오테크놀로지 | 이형접합성 가족성 고콜레스테롤혈증(heFH) 환자의 치료방법 |
| MA43734A (fr) * | 2016-03-03 | 2018-11-28 | Regeneron Pharma | Procédés de traitement de patients atteints d'hyperlipidémie par administration d'un inhibiteur de pcsk9 en combinaison avec un inhibiteur d'angptl3 |
| RS62769B1 (sr) * | 2016-04-08 | 2022-01-31 | Regeneron Pharma | Postupci za lečenje hiperlipidemije inhibitorom angptl8 i inhibitorom angptl3 |
| FI3448426T3 (fi) * | 2016-04-28 | 2025-07-18 | Regeneron Pharma | Menetelmiä familiaalista hyperkolesterolemiaa sairastavien potilaiden hoitoon |
-
2021
- 2021-08-06 CA CA3188213A patent/CA3188213A1/en active Pending
- 2021-08-06 US US17/396,399 patent/US20220072127A1/en not_active Abandoned
- 2021-08-06 MX MX2023001481A patent/MX2023001481A/es unknown
- 2021-08-06 IL IL300429A patent/IL300429A/en unknown
- 2021-08-06 EP EP21762903.9A patent/EP4192446A1/en not_active Withdrawn
- 2021-08-06 CN CN202180058786.0A patent/CN116096365A/zh not_active Withdrawn
- 2021-08-06 AU AU2021320417A patent/AU2021320417A1/en not_active Abandoned
- 2021-08-06 BR BR112023002085A patent/BR112023002085A2/pt unknown
- 2021-08-06 WO PCT/US2021/045008 patent/WO2022032137A1/en not_active Ceased
- 2021-08-06 KR KR1020237007956A patent/KR20230050379A/ko active Pending
- 2021-08-06 JP JP2023507911A patent/JP2023538522A/ja not_active Abandoned
-
2023
- 2023-12-12 US US18/537,578 patent/US20240197870A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022177142A5 (enExample) | ||
| JP2019514907A5 (enExample) | ||
| JP2023538522A5 (enExample) | ||
| JP2022133396A5 (enExample) | ||
| HRP20250797T1 (hr) | Postupci za liječenje pacijenata s obiteljskom hiperkolesterolemijom | |
| JP2013023499A5 (enExample) | ||
| JP2015530867A5 (enExample) | ||
| RU2013139727A (ru) | Антитела человека к pcsk9 для применения в способах лечения конкретных групп индивидуумов | |
| IL277127B1 (en) | Using pcsk9 tracking to reduce cardiovascular risk | |
| JP2014516953A5 (enExample) | ||
| JP2016538248A5 (enExample) | ||
| JP2017528427A5 (enExample) | ||
| JP2025172841A5 (enExample) | ||
| JP2021523188A5 (enExample) | ||
| HRP20200545T1 (hr) | Postupci liječenja ili sprječavanja poremećaja povezanih sa kolesterolom | |
| JP2022000443A5 (enExample) | ||
| RU2015101113A (ru) | Антитела против pcsk9, составы, дозы и способы применения | |
| JP2017506626A5 (enExample) | ||
| JP2012176987A (ja) | 脂質療法用のオメガ−３脂肪酸類及び異常脂質血症薬剤 | |
| RU2008141433A (ru) | Терапия опухолей с использованием сосудистого эндотелиального фактора роста и антитела к рецептору типа 2 человеческого эпителиального фактора роста | |
| JP2016538277A5 (enExample) | ||
| JP2019512472A5 (enExample) | ||
| JP2018508551A5 (ja) | 心血管疾患を処置するか又は心血管疾患のリスクを低減させるためのｅｔｃ１００２及び１種以上のスタチンを含む固定用量組合せ物 | |
| AU2016250388A1 (en) | Treatment for rheumatoid arthritis | |
| IL310115A (en) | Treatment of his hyporesponders |